Identifying and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing

참고문헌 (5)

1. Jun Ho Yi, "Novel combination immunochemotherapy beyond CD20 for B-cell lymphomas", Blood Research, 56, pp.1~4 (2021), 대한혈액학회[DOI]
2. Min Ji Jeon, "Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing", The Korean Journal of Internal Medicine, 38(6), pp.893~902 (2023), 대한내과학회
3. Vega MI, "Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription : pivotal role of p38 MAPK in drug resistance", Oncogene, 23, pp.3530~3540 (2004)
4. Cho BS, "Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia", Cancer Med, 8, pp.501~514 (2019)
5. Samara A, "Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species-and GSK3β-dependent mechanism", Br J Haematol, 192, pp.747~760 (2021)

관련 논문AI추천